The Branded Pharma Fee Deadline Approaches
4 Minute Read
We'll tell you how to prepare. Plus new manufacturer awareness for orphan drugs, midnight changes to MDRP, and upholding the ACA.
4 Minute Read
We'll tell you how to prepare. Plus new manufacturer awareness for orphan drugs, midnight changes to MDRP, and upholding the ACA.
5 Minute Read
This blog is the fourth in a series that shares our vision for future-proofing Market Access. Manufacturers can evolve the Market Access function to work toward their commercial, financial, and...
3 Minute Read
As channels evolve with a shift toward precision medicines, larger patient access obstacles have emerged, and new approaches are needed to transform the world of data aggregation.
5 Minute Read
The latest regulatory updates and reporting reminders for June 2021.
3 Minute Read
In this third installment, we look at operational goals for Market Access. Commercial Operations and Contracting teams need a flexible infrastructure that can support business scale and the changing...
3 Minute Read
Patient tokenization is one of the most mysterious, least understood, and most essential technologies behind actionable patient data. Taken from the Q&A session of IntegriChain's recent Patient Tokenization webinar....
3 Minute Read
In this four-part series, we examine the key goals of Market Access teams as they look to the future with the advent of speciality and precision medicine and how...
4 Minute Read
We dive into the specifics of co-pay offset programs and also examine updates to 340B administrative dispute resolution and ASP reporting as per H.R. 133.
4 Minute Read
This is the first of a series examining the commercial, financial, and operational goals of Market Access, which are all are stymied by data and application silos.